Monday, September 06, 2021 4:37:52 PM
Shareholders paid for it.
Just like the Dr Yost research being used now by BLO and what he took to Bellus.
Dr Williams was Well Paid for his Drug research when BTH re-merged with NASH and an evaluation including a final 'paper' is owed. If he will not/does not give some peer reviewed report, the new CSO and teams should, IMO.
The CT had this BS...
"Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided"
We can 'HOPE' there is IPF/CC data for Ifenprodil that is confirmed by data from the COVID CT. Combined there may be 'significant' results.?.
Enough to sell? Partner? Pump?
Tumors/Cancer/PF/ARDS.?.
...GLTA...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM